|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3456340 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18201976.0 |
| Date of filing the European patent application | 2008-01-08 | |
| (97) | Date of publication of the European application | 2019-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-16 |
| (46) | Date of publication of the claims translation | 2022-05-10 |
| (30) | Number | Date | Country code |
| 87903307 P | 2007-01-08 | US |
| (72) |
STOFFERS, Doris , US
DE LEON, Diva D , US
STANLEY, Charles , US
|
| (73) |
The Trustees of the University of Pennsylvania ,
3160 Chestnut Street, Suite 200, Philadelphia, PA 19104-6283,
US
Children's Hospital of Philadelphia , 3401 Civic Center Boulevard, Philadelphia, PA 19104, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | GLP-1 receptoriaus antagonistas, skirtas įgimto hiperinsulinizmo gydymui |
| GLP-1 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF CONGENITAL HYPERINSULINISM |
| Payment date | Validity (years) | Amount | |
| 2024-12-03 | 18 | 347.00 EUR |
| 2026-01-08 |